Archives

by in
Entry Author Date Location
Acceleron, Celgene Take Aim at Amgen’s Multibillion-Dollar Anemia Market 08/05/11 Boston
Acceleron Gets $25 Million in Partnership Deal With Celgene 08/03/11 Boston
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul 07/05/11 Seattle
Syndax Moves Closer to Pivotal Trials of Selective Lung Cancer Treatment 07/05/11 Boston
Acetylon, Backed by Patriots Owner Bob Kraft, Snags $27M to Develop New Cancer Drugs 06/29/11 Boston
Genentech Scoops Up Tumor-Starving Drug Program From Forma Therapeutics In Rare Deal 06/27/11 Boston
The Quest For Biotech Independence: Maybe It Isn’t So Quixotic After All 06/06/11 National
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company 06/02/11 Seattle
New York Area Companies Head to ASCO With High Hopes For Future Cancer Blockbusters 06/01/11 New York
PerkinElmer Buys Labtronics, Vertex Rival Merck Partners with Genentech, ThermoFisher Acquires Phadia, & More Boston-Area Life Sciences News 05/20/11 Boston
Foundation Medicine Teams With Celgene in Quest to Develop Targeted Cancer Treatments 05/17/11 New York
Forma, After Building Cancer Drug Discovery Engine, Makes First Big Bet on Starving Tumors 03/10/11 Boston
Vitality Acquired By Healthcare Investor Soon-Shiong, Looks to Expand Wireless Products for Improving Healthy Behaviors 02/02/11 Boston
Biogen Idec’s New R&D Boss, Doug Williams, Spurns Corner Office for a Return to Big Science 01/06/11 Boston
Adaptive TCR Seeks to Dominate New Industry, Ultrasound on an iPhone, AVI Names CEO, & More Seattle-Area Life Sciences News 12/16/10 Seattle
AVI Names New CEO 12/13/10 Seattle
Why It’s Noble to Be An Innovator 12/07/10 Boston
Onyx Unveils Results for Myeloma Drug, Raising Stakes in Rivalry with Millennium 12/07/10 San Francisco
Accelerator Reaches Out to East Coast to Find Latest Startup, Acylin Therapeutics 12/01/10 Seattle
Acceleron Pharma Cuts 40 Percent of Workforce 11/03/10 Boston
Acceleron Weans Itself Off VC, Continues its Roll with Pharma Partner Dollars 09/28/10 Boston
It’s True: Using More FDA ‘Wheels’ Under Cancer Drugs Can Speed Approval 09/13/10 San Francisco
Acceleron Snags $498M Deal With Shire to Develop Muscular Dystrophy Drugs 09/09/10 Boston
Cerulean Pharma Makes Progress in Attacking the Big C with Tiny Drugs 09/07/10 Boston
Biogen Strikes Deal with Knopp for ALS Drugs, Selecta Gets New CEO, Avantra Scores $7M, & More Boston-Area Life Sciences News 08/20/10 Boston
Agios, Nourished with $130M Celgene Deal, Expanding Staff and Labs to Starve Cancer 08/19/10 Boston
Onyx Preps for Dash to FDA, After Myeloma Drug Helps Sickest of the Sick 07/26/10 San Francisco
The Mission Bay Biotech Cluster: Antibodies, RNAi, Biofuels, & More 06/29/10 San Francisco
Agios Adds Alnylam Chief to Board 06/24/10 Boston
FerroKin BioSciences Gets $12M 06/17/10 San Francisco
Page 3 of 4 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.